Company Overview
American Vanguard Corporation operates within the Basic Materials sector, specifically focusing on the Agricultural Inputs industry, where it develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts materials to support these diverse applications across its global footprint. As a publicly traded entity, AVD possesses a market capitalization of $58.79M and employs 739 individuals, generating total annual revenue of $515.11M. These financial figures indicate that while the company maintains a significant operational presence and workforce, its market valuation reflects a small-cap status typical of specialized industrial producers with niche market exposure.
Financial Health
The company reported a trailing twelve-month revenue of $515.11M against a net income of $-49,882,000, and an EBITDA of $22.80M, a disparity that reveals a substantial cost structure burden significantly impacting bottom-line profitability despite operational earnings. This negative net income contrasts with the positive EBITDA, highlighting the heavy weight of interest expenses or non-operating costs that erode shareholder value before the final profit calculation. The free cash flow stands at $-4,736,875, indicating that current cash generation is insufficient to cover capital expenditures and operational outflows, which limits the company's immediate financial flexibility for organic expansion or debt reduction. Margin analysis shows a Gross Margin of 28.6%, an Operating Margin of 3.5%, and a Profit Margin of -9.7%, where the low operating margin suggests high fixed costs relative to sales, and the negative profit margin confirms that overhead and financing costs exceed gross profits. On the balance sheet, the company holds $12.43M in cash while carrying $191.39M in debt, resulting in a Debt to Equity ratio of 99.47, which characterizes the balance sheet as highly leveraged rather than conservative. Liquidity is assessed via a Current Ratio of 1.77, suggesting the company possesses sufficient short-term assets to cover its current liabilities, though this buffer is narrow given the high debt load. Return on Equity is -23.4% and Return on Assets is 0.4%, metrics that reveal management effectiveness is currently challenged by significant losses relative to the capital base and asset utilization.
Valuation Assessment
The valuation metrics present a trailing P/E Ratio (TTM) of N/A due to negative earnings, while the Forward P/E is 5.28, a difference that implies the market prices the stock based on anticipated future profitability rather than current historical performance. The Price to Book ratio is 0.31, indicating that the stock trades at a significant discount to its book value, suggesting the market assigns a low premium to the company's tangible assets. Alternative valuation measures include a Price to Sales ratio of 0.11 and an EV/EBITDA of 10.43, which suggest the company is valued on a conservative basis relative to its revenue and earnings before interest, taxes, depreciation, and amortization. Price action over the last year has seen the stock trade between a 52-Week High of $5.92 and a 52-Week Low of $2.05, meaning the current price sits within a volatile range that reflects significant uncertainty regarding future earnings realization. The stock exhibits a Beta of 1.24, which explains that the share price is more volatile than the broader market, amplifying movements in the Basic Materials sector and reacting more sharply to macroeconomic or commodity price shifts.
Growth & Income
Revenue Growth (YoY) stands at -9.0% and Earnings Growth (YoY) is N/A, indicating that the company is currently contracting in terms of sales and lacks a positive earnings trajectory to sustain growth in the immediate term. The company does not pay dividends, evidenced by a Dividend Yield of N/A and a Payout Ratio of 0.0%, meaning it reinvests all available earnings—or in this case, retains losses—rather than distributing income to shareholders. This non-dividend profile aligns with a capital preservation strategy often seen in leveraged companies facing negative net income, where cash is prioritized for debt servicing or operational restructuring over shareholder returns. The overall growth and income profile is characterized by negative revenue momentum and a complete absence of dividend income, presenting a high-risk, high-reward scenario dependent on a turnaround in operating performance to restore positive cash flow and profitability.